Intel announced on Monday that it plans to raise $15 billion through a share sale to fund the expansion of its semiconductor contract manufacturing business. The company is currently investing in new facilities and advanced packaging capabilities as it attempts to compete with industry leaders like TSMC in the foundry market.
The decision follows a period of stock growth for the chipmaker, with its share price nearly tripling this year as of the last close. However, shares fell more than 4% in early trading following the announcement. Analysts, including Russ Mould of AJ Bell, stated that the equity raise was expected given the company's capital-intensive expansion goals and recent stock performance.
The capital raise comes as Intel increases its financial commitments to manufacturing. In July, the company raised its 2026 capital expenditure forecast from $18 billion to $20 billion, citing increased demand for central processing units driven by artificial intelligence. Additionally, Intel recently announced a 5 billion euro ($5.77 billion) investment to expand its manufacturing hub in Ireland, representing over 25% of its planned capital spending for the year.
The scale of this move is tied to Intel's shift toward becoming a major "foundry," or a contract manufacturer for other companies' chips. The $15 billion raised will support a capital expenditure budget that was recently increased to $20 billion for the year. This funding is necessary for Intel to reach high-volume production of its "14A" manufacturing process by 2028. While Tesla has signed on as a customer for this technology, the success of this capital injection depends on Intel securing additional high-volume clients to justify the cost of these new facilities.
The outcome of this sale will influence Intel’s ability to compete with global leaders like TSMC and domestic rivals like AMD and Nvidia. If successful, the expansion could shift where global electronics are manufactured, potentially moving more production to Intel’s facilities in the U.S. and Europe, such as the expanded site in Ireland. Investors will be watching for confirmation of rumored clients, such as Apple, which President Donald Trump previously stated would work with Intel. The share sale includes a 30-day option for underwriters, including JPMorgan and Goldman Sachs, to purchase additional shares.